Delivery Order SPE2DB22D9112-SPE2DB25FTKRN
Award Date 9/29/25
Potential Completion Date 9/30/25
Potential Value $34K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,311.35 by the Defense Logistics Agency on June 30, 2025, for the supply of Xtandi 40 mg capsules (120-count). This firm fixed-price delivery order, with an ultimate completion date of July 1, 2025, carries no set-aside designation and represents a continuation of the company's significant role in the federal pharmaceutical supply chain....
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units) under a firm fixed-price contract valued at $8,622.72. The contract, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing...
- The Defense Logistics Agency awarded a delivery order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, carries no set-aside designation. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- The Defense Logistics Agency awarded a $12,934.05 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a $267,357.79 delivery order to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units) with a completion date of September 29, 2025. This firm fixed-price delivery order was issued without a set-aside designation, allowing the woman-owned small business based in Park Ridge, Illinois to compete directly in the federal pharmaceutical procurement market. The award leverages DMS Pharmaceutical Group's established capability as a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,622.72 by the Defense Logistics Agency on August 25, 2025, for the supply of Xtandi 40 mg capsules (120-count). The contract carries no set-aside designation and is scheduled for completion by August 26, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 120 capsules of Xtandi 40 mg with a ceiling value of $4,311.35. This firm fixed-price delivery order, issued on July 17, 2025, with an ultimate completion date of July 18, 2025, represents a single-line item fulfillment under the company's larger contract vehicle. The award carries no set-aside designation, allowing...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $39,898 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40mg capsules (120 count). This firm fixed-price delivery order, issued September 13, 2025, represents a direct procurement requiring fulfillment at the vendor's facility in Park Ridge, Illinois. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its status as a woman-owned...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, valued at $10,222.72, is scheduled for completion by July 31, 2025, and was issued on July 30, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis. This...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count packages). The contract, valued at $4,311.35, carries a firm fixed-price arrangement with an ultimate completion date of September 29, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete directly in open federal procurement...